Correlation Between Pharmadrug and Cannabis Strategic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmadrug and Cannabis Strategic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmadrug and Cannabis Strategic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmadrug and Cannabis Strategic Ventures, you can compare the effects of market volatilities on Pharmadrug and Cannabis Strategic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmadrug with a short position of Cannabis Strategic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmadrug and Cannabis Strategic.

Diversification Opportunities for Pharmadrug and Cannabis Strategic

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pharmadrug and Cannabis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmadrug and Cannabis Strategic Ventures in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Strategic and Pharmadrug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmadrug are associated (or correlated) with Cannabis Strategic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Strategic has no effect on the direction of Pharmadrug i.e., Pharmadrug and Cannabis Strategic go up and down completely randomly.

Pair Corralation between Pharmadrug and Cannabis Strategic

If you would invest  0.95  in Pharmadrug on December 30, 2024 and sell it today you would lose (0.13) from holding Pharmadrug or give up 13.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy96.77%
ValuesDaily Returns

Pharmadrug  vs.  Cannabis Strategic Ventures

 Performance 
       Timeline  
Pharmadrug 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmadrug are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Pharmadrug reported solid returns over the last few months and may actually be approaching a breakup point.
Cannabis Strategic 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cannabis Strategic Ventures has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Cannabis Strategic is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pharmadrug and Cannabis Strategic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmadrug and Cannabis Strategic

The main advantage of trading using opposite Pharmadrug and Cannabis Strategic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmadrug position performs unexpectedly, Cannabis Strategic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Strategic will offset losses from the drop in Cannabis Strategic's long position.
The idea behind Pharmadrug and Cannabis Strategic Ventures pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance